Q&A clinic on Product Management Service (PMS) Product User Interface - 6 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 June 2024, 15:30 (CEST) to 6 June 2024, 16:00 (CEST)
Q&A clinic on Product Management Service (PMS) Product User Interface - 27 June 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 June 2024, 15:30 (CEST) to 27 June 2024, 16:00 (CEST)
Veterinary medicines European public assessment report (EPAR): Divence Penta, Bovine respiratory syncytial virus, strain LYM-56, Live / Infectious bovine rhinotracheitis virus, strain CEDDEL, gE- tk- double-gene deleted, Live / Bovine parainfluenza virus 3, strain SF-4 Reisinger, Inactivated / Bovine viral diarrhoea virus 1, E2 recombinant protein / Bovine viral diarrhoea virus 2, E2 recombinant protein, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Enteroporc Coli, Neonatal piglet colibacillosis vaccine (recombinant, inactivated), Status: Withdrawn
Eighth Industry Standing Group (ISG) meeting, European Medicines Agency, Amsterdam, the Netherlands, 25 March 2024
User guide for micro, small and medium-sized enterprises
Veterinary medicines European public assessment report (EPAR): Meloxoral, meloxicam, Status: Authorised
Human medicines European public assessment report (EPAR): Kinharto, Omecamtiv mecarbil, Date of refusal: 07/05/2024, Status: Withdrawn application
Minutes of the CVMP meeting 16-18 April 2024
Cancer Medicines Forum workshop: April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 April 2024, 13:00 (CEST) to 5 April 2024, 18:00 (CEST)